Project Grant R43DA061396
Award Date 8/1/24
Completion Date 7/31/25
Dollars Obligated $587K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $386,452 to Electronic Biosciences, Inc. to develop rapid fingerstick diagnostics for opioid and stimulant use disorders. The award period is from April 1, 2025 to March 31, 2026. The project aims to address the escalating public health crisis of opioid and stimulant use disorders, which have contributed to over 107,000 overdose deaths in the...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $305,369 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Taesun, LLC in Colorado. The grant, with a period of performance from August 1, 2025 to January 31, 2026, is for the development of a comprehensive device that integrates fentanyl test strips with sample preparation features to enable convenient and discreet fentanyl testing in high-risk environments....
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,576,513 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Instanosis Inc., a woman-owned small business in Pennsylvania. The goal of this 2-year project is to develop the first FDA-cleared oral fluid fentanyl rapid test that is 10 times more sensitive, 4 times faster, and requires 10 times less oral fluid volume compared to commercially available forensic...
- This $304,215 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and validation of a novel software platform for decentralized clinical trials in substance use disorder (SUD) research. The software will incorporate large language models to address challenges in SUD clinical trials, such as participant diversity, recruitment, and retention. The award recipient, Carina Medical LLC, is a...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $306,528 to Addinex Technologies, Inc. to adapt their existing medication management system for use in decentralized clinical trials for substance use disorder (SUD). The primary goal is to develop a system that allows for at-home dispensing of medication, with features such as smartphone app-controlled dispensers using one-time passcodes,...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- This Project Grant award of $400,000 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Mountainpass Technology LLC, a for-profit company in Chevy Chase, Maryland. The funding will support the development of "MyTrials", an integrated remote biomarker capture system for decentralized clinical trials focused on substance use disorders. The project aims to address key methodological limitations in remote...
- This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development of a software-based medical device (SAMD) for detecting opioid use through voice analysis. The $800,000 award to Tenvos Inc., a minority-owned and woman-owned technology company, aims to advance the company's AI-driven solution that can enable patients to remotely test for opioid use and securely share results with...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will evaluate the benefits of a hand-held, automated, personalized oral liquid dispensing system for take-home methadone medication management for patients with opioid use disorder (OUD). The $326,410 award, with a performance period from June 1, 2025 to May 31, 2026, will support a clinical program delivered by Berkshire Biomedical Corporation. The project aims to...